UArizona Arthritis Center using $3.4 million grant to study knees Oct. 22, 2022 Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health. Arizona Daily Star
Favorite places: Health Sciences Innovation Building Oct. 21, 2022 Architect Damon Leverett shares what makes the University of Arizona’s Health Sciences Innovation Building such an architectural wonder. Arizona Public Media
More evidence sleep counts toward heart health Oct. 21, 2022 A new study shows that including how long a person sleeps in a heart health score was able to predict heart disease risk among older adults. WebMD
Will the bivalent booster cause worse side effects? Oct. 21, 2022 Experts say side effects from the bivalent COVID-19 vaccines won't be as bad as previous vaccines, and side effects such as fevers and chills tend to be short-lived. The Atlantic
Fountain Life partners with Global Wellness Institute for the Wellness Moonshot Oct. 20, 2022 Fountain Life will be the 2023 sponsor of the Global Wellness Institute's Wellness Moonshot campaign to create a world free of preventable disease. Club & Resort Business
Analgesic use after COVID-19 vaccination does not negatively affect antibody responses Oct. 20, 2022 UArizona Health Sciences research published as a preprint on medRxiv showed no evidence that the use of analgesics following COVID-19 vaccination had a negative effect on antibody responses. News Medical
New Center Leads Collaborative Research to Improve Firefighter Health Oct. 19, 2022 Researchers will study firefighter occupational health risks to help inform decisions, practices and policies to improve firefighter safety and health. Read more Image
Melatonin can be a nightmare if used incorrectly, experts say Oct. 19, 2022 Melatonin supplements are designed to mimic the effects of the hormone, boosting its levels within the body to induce sleep. United Press International
Certain class of diabetes meds could cut dementia risk Oct. 19, 2022 Xin Tang, a student in the Mel and Enid Zuckerman College of Public Health, is the first author on a paper that found that in patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy. HealthDay
How Mentorship Makes Research Happen Oct. 19, 2022 Amanda Wilson, PhD, reflects on how guidance from experienced public health researchers helped her navigate roadblocks in her work to improve cleaning workers’ respiratory health. Read more Image